News
Stay up to date on topics that are important to Nurse Practitioners.
-
National NP Practitioner Residency & Fellowship Training Consortium Receives Federal Recognition as Accrediting Agency
The National Nurse Practitioner Residency & Fellowship Training Consortium received federal recognition as accrediting agency by the US…
-
CDC Updates and Shortens Recommended Isolation and Quarantine Period for General Population
Citing what is currently known about COVID-19 and the Omicron variant, the CDC is shortening the recommended time…
-
CDC Recommends Expanded Eligibility of COVID-19 Booster to Children 12 to 15 Years Old
The CDC endorsed the FDA’s Advisory Committee on Immunization Practices’ (ACIP) recommendation to expand eligibility of booster doses…
-
CDC Updates Recommendation for Pfizer Booster to 5 Months After Primary Series
The CDC has updated its recommendation for when many people can receive a booster shot after the primary…
-
FDA Authorizes Merck’s Oral Antiviral for Treatment of COVID-19 in Certain Adults
The FDA issued an emergency use authorization (EUA) for Merck’s molnupiravir for the treatment of mild-to-moderate COVID-19 in…
-
FDA Authorizes Pfizer’s Oral Antiviral for COVID-19 in Adults, Pediatric Patients 12 Years and Older
The FDA issued an emergency use authorization (EUA) for Pfizer’s oral antiviral nirmatrelvir/ritonavir tablets, co-packaged for oral use…
-
Add-On Therapy Approved to Lower LDL Cholesterol in High-Risk Patients
The FDA approved inclisiran (Leqvio) injection as an adjunct to diet and maximally tolerated statin therapy for the…
-
New Biologic Drug Approved for Moderate to Severe Atopic Dermatitis
The FDA approved tralokinumab-ldrm (Adbry), a biologic for the treatment of moderate-to-severe atopic dermatitis in adults 18 years…
-
FDA Approves New Drug for Insomnia in Adults
The FDA has approved daridorexant (Quviviq) 25 mg and 50 mg for the treatment of adult patients with…
-
AAN Updated Guideline for Treatment of Painful Diabetic Neuropathy: Top Takeaways
Painful diabetic neuropathy (PDN) is a highly prevalent condition that greatly affects quality of life. The American Academy…
-
Nurse Practitioner Ranked as Top Healthcare Job in 2022
U.S. News & World Report ranked the nurse practitioner role: First on its 2022 Best Health Care Jobs…
-
Monoclonal Antibody Therapy for COVID-19 Authorized for Pediatric Patients, Including Newborns
The FDA issued an emergency use authorization (EUA) of bamlanivimab and etesevimab—previously authorized for pediatric patients 12 year…
Trending
Join our email list
Get new course alerts, newsletters and more delivered directly to your inbox
By providing my personal information, including phone number, I consent to (1) receive email messages with information and offers, autodialed calls, texts, and prerecorded messages from FHEA, including current and possible future services, customer service and billing; and (2) FHEA’s Privacy Policy and Terms and Conditions. I understand that my consent is not required to purchase, and that cancellation of purchase does not automatically revoke this consent.